» Articles » PMID: 20065021

Intracellular Trafficking of Bordetella Pertussis in Human Macrophages

Overview
Journal Infect Immun
Date 2010 Jan 13
PMID 20065021
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Although Bordetella pertussis has been observed to survive inside macrophages, its ability to resist or evade degradation in phagolysosomes has not been defined. We here investigated the trafficking of B. pertussis upon entry into human macrophages. During the first hours following phagocytosis, a high percentage of bacteria were destroyed within acidic compartments positive for the lysosome-associated membrane proteins (LAMP). However, roughly one-fourth of the bacteria taken up evade this initial killing event, remaining in nonacidic compartments. Forty-eight hours after infection, the number of intracellular bacteria per cell increased, suggesting that B. pertussis is capable of replicating in this type of compartment. Viable bacteria accumulated within phagosomal compartments positive for the early endosomal marker Rab5 but not the late endosomal marker LAMP. Moreover, B. pertussis-containing phagosomes acquired exogenously added transferrin, indicating that intracellular bacteria have access to extracellular components and essential nutrients via the host cell recycling pathway. Overall, these results suggest that B. pertussis survives and eventually replicates in compartments with characteristics of early endosomes, potentially contributing to its extraordinary ability to persist within hosts and populations.

Citing Articles

Eosinophils as drivers of bacterial immunomodulation and persistence.

Parrish K, Gestal M Infect Immun. 2024; 92(9):e0017524.

PMID: 39007622 PMC: 11385729. DOI: 10.1128/iai.00175-24.


Combined regulation of pro-inflammatory cytokines production by STAT3 and STAT5 in a model of infection of alveolar macrophages.

Khiter F, Kherrouche Z, Dubois V, Slupek S, Petit E, Debrie A Front Immunol. 2023; 14:1254276.

PMID: 37841236 PMC: 10569487. DOI: 10.3389/fimmu.2023.1254276.


and : Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations.

Miguelena Chamorro B, De Luca K, Swaminathan G, Longet S, Mundt E, Paul S Clin Microbiol Rev. 2023; 36(3):e0016422.

PMID: 37306571 PMC: 10512794. DOI: 10.1128/cmr.00164-22.


Avirulent phenotype promotes adaptation to the intramacrophage environment.

Farman M, Petrackova D, Kumar D, Drzmisek J, Saha A, curnova I Emerg Microbes Infect. 2022; 12(1):e2146536.

PMID: 36357372 PMC: 9858536. DOI: 10.1080/22221751.2022.2146536.


Natural History and Ecology of Interactions Between Species and Amoeba.

Ma L, Linz B, Caulfield A, Dewan K, Rivera I, Harvill E Front Cell Infect Microbiol. 2022; 12:798317.

PMID: 35223538 PMC: 8863592. DOI: 10.3389/fcimb.2022.798317.


References
1.
Rodriguez M, Hellwig S, Hozbor D, Leusen J, van der Pol W, van de Winkel J . Fc receptor-mediated immunity against Bordetella pertussis. J Immunol. 2001; 167(11):6545-51. DOI: 10.4049/jimmunol.167.11.6545. View

2.
Shumilla J, Lacaille V, Hornell T, Huang J, Narasimhan S, Relman D . Bordetella pertussis infection of primary human monocytes alters HLA-DR expression. Infect Immun. 2004; 72(3):1450-62. PMC: 356037. DOI: 10.1128/IAI.72.3.1450-1462.2004. View

3.
Mobberley-Schuman P, Weiss A . Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun. 2005; 73(11):7317-23. PMC: 1273866. DOI: 10.1128/IAI.73.11.7317-7323.2005. View

4.
Hellwig S, Hazenbos W, van de Winkel J, Mooi F . Evidence for an intracellular niche for Bordetella pertussis in broncho-alveolar lavage cells of mice. FEMS Immunol Med Microbiol. 1999; 26(3-4):203-7. DOI: 10.1111/j.1574-695X.1999.tb01391.x. View

5.
Ishibashi Y, Claus S, Relman D . Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). J Exp Med. 1994; 180(4):1225-33. PMC: 2191706. DOI: 10.1084/jem.180.4.1225. View